NR4A2 and uterine cervix carcinoma in situ: There were no significant changes with respect to the receptor NR4A2, although a tendency to overexpression was observed in cervicitis and CIN III in contrast to NR4A3, which was significantly expressed in CIN I but not in cervicitis or CIN III, a fact that could be explained by functional redundancy exhibited by these receptors [14].